Search Page

1

Cite

Share

MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases.

Wang X, He Y, Mackowiak B, Gao B. Wang X, et al. Among authors: gao b. Gut. 2021 Apr;70(4):784-795. doi: 10.1136/gutjnl-2020-322526. Epub 2020 Oct 30. Gut. 2021. PMID: 33127832 Review.

Cite

Share

2

Cite

Share

TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.

Park HS, Song JW, Park JH, Lim BK, Moon OS, Son HY, Lee JH, Gao B, Won YS, Kwon HJ. Park HS, et al. Among authors: gao b. Autophagy. 2020 Nov 16:1-16. doi: 10.1080/15548627.2020.1834711. Online ahead of print. Autophagy. 2020. PMID: 33190588

Cite

Share

3

Cite

Share

Myeloid-Cell-Specific IL-6 Signaling Promotes MicroRNA-223-Enriched Exosome Production to Attenuate NAFLD-Associated Fibrosis.

Hou X, Yin S, Ren R, Liu S, Yong L, Liu Y, Li Y, Zheng MH, Kunos G, Gao B, Wang H. Hou X, et al. Among authors: gao b. Hepatology. 2020 Nov 24:10.1002/hep.31658. doi: 10.1002/hep.31658. Online ahead of print. Hepatology. 2020. PMID: 33236445

Cite

Share

4

Cite

Share

Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma.

Zhang Q, Ma C, Duan Y, Heinrich B, Rosato U, Diggs LP, Ma L, Roy S, Fu Q, Brown ZJ, Wabitsch S, Thovarai V, Fu J, Feng D, Ruf B, Cui LL, Subramanyam V, Frank KM, Wang S, Kleiner DE, Ritz T, Rupp C, Gao B, Longerich T, Kroemer A, Wang XW, Ruchirawat M, Korangy F, Schnabl B, Trinchieri G, Greten TF. Zhang Q, et al. Among authors: gao b. Cancer Discov. 2021 May;11(5):1248-1267. doi: 10.1158/2159-8290.CD-20-0304. Epub 2020 Dec 15. Cancer Discov. 2021. PMID: 33323397

Cite

Share

5

Cite

Share

Immunopathobiology and therapeutic targets related to cytokines in liver diseases.

He Y, Hwang S, Ahmed YA, Feng D, Li N, Ribeiro M, Lafdil F, Kisseleva T, Szabo G, Gao B. He Y, et al. Among authors: gao b. Cell Mol Immunol. 2021 Jan;18(1):18-37. doi: 10.1038/s41423-020-00580-w. Epub 2020 Nov 17. Cell Mol Immunol. 2021. PMID: 33203939 Review.

Cite

Share

6

Cite

Share

Nrf2 Activator PB125^® as a Potential Therapeutic Agent against COVID-19.

McCord JM, Hybertson BM, Cota-Gomez A, Geraci KP, Gao B. McCord JM, et al. Among authors: gao b. Antioxidants (Basel). 2020 Jun 12;9(6):518. doi: 10.3390/antiox9060518. Antioxidants (Basel). 2020. PMID: 32545518 Free PMC article.

Cite

Share

7

Cite

Share

Interleukin-22 in alcoholic hepatitis and beyond.

Xiang X, Hwang S, Feng D, Shah VH, Gao B. Xiang X, et al. Among authors: gao b. Hepatol Int. 2020 Sep;14(5):667-676. doi: 10.1007/s12072-020-10082-6. Epub 2020 Sep 5. Hepatol Int. 2020. PMID: 32892258 Review.

Cite

Share

8

Cite

Share

COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management.

Wang Z, Yang Y, Liang X, Gao B, Liu M, Li W, Chen Z, Wang Z. Wang Z, et al. Among authors: gao b. Front Neurol. 2020 Oct 27;11:571996. doi: 10.3389/fneur.2020.571996. eCollection 2020. Front Neurol. 2020. PMID: 33193019 Free PMC article. Review.

Cite

Share

9

Cite

Share

Nrf2 Activator PB125® as a Potential Therapeutic Agent Against COVID-19.

McCord JM, Hybertson BM, Cota-Gomez A, Gao B. McCord JM, et al. Among authors: gao b. bioRxiv. 2020 May 17:2020.05.16.099788. doi: 10.1101/2020.05.16.099788. Preprint. bioRxiv. 2020. PMID: 32511372 Free PMC article. Updated.

Cite

Share

10

Cite

Share

Intestinal Virome in Patients With Alcoholic Hepatitis.

Jiang L, Lang S, Duan Y, Zhang X, Gao B, Chopyk J, Schwanemann LK, Ventura-Cots M, Bataller R, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS Jr, Vargas V, Altamirano J, Caballería J, Shawcross DL, Ho SB, Louvet A, Lucey MR, Mathurin P, Garcia-Tsao G, Kisseleva T, Brenner DA, Tu XM, Stärkel P, Pride D, Fouts DE, Schnabl B. Jiang L, et al. Among authors: gao b. Hepatology. 2020 Dec;72(6):2182-2196. doi: 10.1002/hep.31459. Epub 2020 Oct 10. Hepatology. 2020. PMID: 32654263 Free PMC article.

Cite

Share